Recent Updates
Recently added Catalysts
LFCR Positive Sentiment Score: 70/100

Lifecore Biomedical to Participate in William Blair 46th Annual Growth Stock Conference

Thursday, May 21, 2026 1 min read
Key Takeaway: Lifecore Biomedical, a contract development and manufacturing organization, has announced its participation in the upcoming William Blair 46th Annual Growth Stock Conference. The event is scheduled for June 2-4, 2026, in Chicago, Illinois. Key executives from Lifecore, including CEO Paul Josephs and CFO Ryan Lake, will attend and engage in investor meetings. This participation highlights Lifecore's commitment to attracting investor attention and fostering relationships within the biopharmaceutical sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • Lifecore Biomedical is participating in a significant industry conference, which enhances visibility.
  • The involvement of high-level executives suggests potential investor interest and engagement.
  • The company's expertise in injectable products emphasizes its strong market position.

Full Press Release Details

CHASKA, Minn., May 21, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), today announced that the company will participate in the William Blair 46th Annual Growth Stock Conference. The conference will take place June 2-4, 2026, in Chicago, IL.
Details regarding Lifecore’s participation are as follows:
William Blair 46th Annual Growth Stock Conference
Details: Lifecore management, including Paul Josephs, chief executive officer, and Ryan Lake, chief financial officer, will participate in investor meetings.
Conference Dates: June 2-4, 2026
Location: Loews Chicago Hotel, Chicago, IL
About Lifecore Biomedical
Lifecore Biomedical, Inc. (Nasdaq: LFCR) is a fully integrated contract development and manufacturing organization (CDMO) that offers highly differentiated capabilities in the development, fill and finish of sterile injectable pharmaceutical products in syringes, vials, and cartridges, including complex formulations. As a leading manufacturer of premium, injectable-grade hyaluronic acid, Lifecore brings more than 40 years of expertise as a partner for global and emerging biopharmaceutical and biotechnology companies across multiple therapeutic categories to bring their innovations to market. For more information about the company, visit Lifecore’s website at www.lifecore.com.
Contact Information:
Vida Strategic Partners
Stephanie Diaz (Investors)
Jennifer Arcure (Media)
ryan.lake@lifecore.com

Frequently Asked Questions

When is the William Blair Conference Lifecore will attend?

Lifecore will attend the William Blair Conference from June 2-4, 2026.

Where will the William Blair Conference be held?

The conference will be held at the Loews Chicago Hotel in Chicago, IL.

Who from Lifecore will participate in the conference?

Lifecore CEO Paul Josephs and CFO Ryan Lake will participate in the conference.

What is Lifecore Biomedical's main focus?

Lifecore specializes in contract development and manufacturing of injectables.

How long has Lifecore been in the industry?

Lifecore has over 40 years of experience in the biopharmaceutical field.

Tags: LFCR Viatris Investor Conferences Healthcare biopharmaceutical injectables Chicago growth stock conference
Last updated: May 21, 2026